Search Medical Condition
Please enter condition
Please choose location

Lung Injury Clinical Trials

A listing of Lung Injury medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (31) clinical trials

You must be 40 years of age or older You must have a diagnosis of COPD for at least a year You must currently be treating your COPD with a daily medication for at least 8 weeks prior to starting the study You must be a current or former smoker ...

Phase N/A

This study will be testing an investigational medication for COPD Eligibility Criteria: -Age 40 years or older -Diagnosis of COPD for at least 12 months -Current Smoker or Ex-Smoker -Other criteria may apply Other Details: Qualified volunteers will receive study medication, study supplies and any study required testing at no ...

Phase

We are currently looking for study participants who have been diagnosed with COPD, Chronic Bronchitis or Emphysema. We currently have 3 different COPD studies that are being conducted at Clinsite. Please call or e-mail us for more information and to see if you qualify for one of our studies. Call ...

Phase N/A

Summary: A clinical research study of an investigational medication used for individuals with Chronic Obstructive Pulmonary Disease (COPD).

Phase

Summary: A clinical research study for an investigational medication for Chronic Obstructive Pulmonary Disease (COPD).

Phase

This is a randomized, double-blind, multi-center, parallel group study to assess the efficacy and safety of BGF MDI 320/14.4/9.6 μg and BGF MDI 160/14.4/9.6 μg relative to GFF MDI 14.4/9.6 μg and BFF MDI 320/9.6 μg over a 52-week treatment period in 8,000 subjects with moderate to very severe COPD ...

Phase

This study is being done to learn more about the study drug, Nintedanib, and to learn if there are blood tests that can help see how the study drug affects IPF.

Phase

The primary purpose of this study is to demonstrate improvements in lung function for subjects treated with UMEC/VI compared with UMEC for 24 weeks. The effect of UMC/VI, UMEC, and salmeterol with respect to patient HRQoL measured through patient reported outcomes (PROs) Questionnaires, symptoms and lung function will also be ...

Phase

We are looking for individuals to participate in a research study to determine the safety and efficacy of an investigational medication. Eligibility Criteria: If you are: - 40 years of age or older - are a previous or current smoker - have a diagnosis of chronic obstructive pulmonary disease (COPD) ...

Phase N/A